Paralkar Lab, ribosome biogenesis, ribosome hematopoiesis, leukemia, transcription, epigenetics

Grant from National Institutes of Health

Charles Antony, Post-Doctoral Researcher, is awarded a Co-Operative Center for Excellence in Hematology (CCEH) Type B grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to study transcription factor dynamics and regulation in primary human bone marrow.

Equipment award from National Institutes of Health

The Paralkar Lab is awarded an equipment award by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) to purchase a dedicated Sony benchtop SH800 cell flow sorter.

Grant from National Institutes of Health

The Paralkar Lab is awarded a Co-Operative Center for Excellence in Hematology (CCEH) grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to model the effect of RUNX1 point mutations on mouse hematopoietic stem and progenitor cells.

Grant from National Institutes of Health

The Paralkar Lab is awarded a MIRA R35 grant by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) to study the regulation of ribosomal RNA transcription in mammalian tissues.